Company

회사연혁

차세대 세포유전자치료제 개발 전문 기업

아피셀테라퓨틱스

HISTORY
2022
  • 5

    Selected for a government project of the Ministry of Trade, Industry and Energy

  • 4

    Selected as a target of two by the Korean Fund for Regenerative Medicine(KFRM) (3.6 billion won)

2021
  • 7

    Opened AffyXell Innovation Cube (AIC), Gimhae

  • 2

    Approved as research institute by KOITA (Korea Industrial Technology Association)

  • 1

    $7.3 Million series A Financing

2020
  • 12

    Approval of LMO facility, AFX platform R&D Center (Gwanggyo)
    Selected of government R&D project by Ministry of Science and ICT.

  • 11

    1st vial cracking ceremony

  • 10

    Founded AFX platform R&D center

  • 9

    Headquarters relocated to Gimhae

  • 3

    Daewoong AffyXell TF launched

  • 2

    Registered a business

  • 1

    Incorporated ‘AffyXell Therapeutics Co. Ltd.,’